Hi NZ
I find it interesting that this research is based out of Sydney Uni, because Pitney pharmaceuticals is Sydney Uni based/owned.
Their could be collaboration of our trial and their research parameters in the future
Cheers
Bunyip
Ann: First Patient of Cohort 2 Dosed in MND Trial, page-40
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.010(4.88%) |
Mkt cap ! $94.85M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 19.0¢ | $200.3K | 1.007M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 235531 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |